Elevated levels of multiple biomarkers of alzheimer's disease in the aqueous humor of eyes with open-angle glaucoma

Investigative Ophthalmology and Visual Science

Volumn 54, Issue 8, 2013, Pages 5353-5358

  Inoue, Toshihiro ^a   Kawaji, Takahiro ^a   Tanihara, Hidenobu ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

Author keywords

Alzheimer's disease; Apolipoprotein; Aqueous humor; Biomarker; Glaucoma

Indexed keywords

ALPHA 2 MACROGLOBULIN; APOLIPOPROTEIN A1; APOLIPOPROTEIN C3; APOLIPOPROTEIN E; BIOLOGICAL MARKER; COMPLEMENT COMPONENT C3; COMPLEMENT FACTOR H; PREALBUMIN;

ADULT; AGED; ALZHEIMER DISEASE; AQUEOUS HUMOR; ARTICLE; CATARACT; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE SEVERITY; FEMALE; HUMAN; IMMUNOASSAY; MAJOR CLINICAL STUDY; MALE; OPEN ANGLE GLAUCOMA; PATHOPHYSIOLOGY; PERIMETRY; PRIORITY JOURNAL; PSEUDOEXFOLIATION; VISUAL FIELD DEFECT;

ALZHEIMER'S DISEASE; APOLIPOPROTEIN; AQUEOUS HUMOR; BIOMARKER; GLAUCOMA;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; AQUEOUS HUMOR; BIOLOGICAL MARKERS; CROSS-SECTIONAL STUDIES; DISEASE PROGRESSION; ENZYME-LINKED IMMUNOSORBENT ASSAY; EYE PROTEINS; FEMALE; GLAUCOMA, OPEN-ANGLE; HUMANS; MALE; MIDDLE AGED; SEVERITY OF ILLNESS INDEX;

EID: 84881540722     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.13-12245     Document Type: Article

References (43)

1. Quigley HA, Broman AT. The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol. 2006;90:262-267.
2. Inoue T, Kawaji T, Inatani M, Kameda T, Yoshimura N, Tanihara H. Simultaneous increases in multiple proinflammatory cytokines in the aqueous humor of pseudophakic glaucomatous eyes. J Cataract Refract Surg. 2012;38:1389-1397.
3. Fagan AM, Perrin RJ. Upcoming candidate cerebrospinal fluid biomarkers of Alzheimer's disease. Biomark Med. 2012;6:455- 476.
4. Kim J, Basak JM, Holtzman DM. The role of apolipoprotein E in Alzheimer's disease Neuron. 2009;63:287-303.
5. Buxbaum JN, Ye Z, Reixach N, et al. TTR protects Alzheimer's mice from the behavioral and biochemical effects of Abeta toxicity. Proc Natl Acad Sci U S A. 2008;105:2681-2686.
6. Li X, Masliah E, Reixach N, Buxbaum JN. Neuronal production of TTR in human and murine Alzheimer's disease: is it protective? J Neurosci. 2011;31:12483-12490.
7. Bayer AU, Keller ON, Ferrari F, Maag KP. Association of glaucoma with neurodegenerative diseases with apoptotic cell death: Alzheimer's disease and Parkinson's disease. Am J Ophthalmol. 2002;133:135-137.
8. Bayer AU, Ferrari F, Erb C. High occurrence rate of glaucoma among patients with Alzheimer's disease. Eur Neurol. 2002; 47:165-168.
9. Tamura H, Kawakami H, Kanamoto T, et al. High frequency of open-angle glaucoma in Japanese patients with Alzheimer's disease. J Neurol Sci. 2006;246:79-83.
10. Kesler A, Vakhapova V, Korczyn AD, Naftaliev E, Neudorfer M. Retinal thickness in patients with mild cognitive impairment and Alzheimer's disease. Clin Neurol Neurosurg. 2011;113: 523-526.
11. Saccà SC, Centofanti M, Izzotti A. New proteins as vascular biomarkers in primary open angle glaucomatous aqueous humor. Invest Ophthalmol Vis Sci. 2012;53:4242-4253.
12. Duan X, Xue P, Wang N, Dong Z, Lu Q, Yang F. Proteomic analysis of aqueous humor from patients with primary open angle glaucoma. Mol Vis. 2010;16:2839-2846.
13. Grus FH, Joachim SC, Sandmann S, et al. TTR and complex protein pattern in aqueous humor of patients with primary open-angle glaucoma. Mol Vis. 2008;14:1437-1445.
14. 2-macroglobulin accumulates in aqueous humor and binds to nerve growth factor, neutralizing neuroprotection. Invest Ophthalmol Vis Sci. 2011;52:5260- 5265.
15. Tripathi RC, Li J, Chan WF, Tripathi BJ. Aqueous humor in glaucomatous eyes contains an increased level of TGF-2. Exp Eye Res. 1994;59:723-727.
16. Tripathi RC, Li J, Tripathi BJ, Chalam KV, Adamis AP. Increased level of vascular endothelial growth factor in aqueous humor of patients with neovascular glaucoma. Ophthalmology. 1998; 105:232-237.
17. Welge-Lussen U, May CA, Neubauer AS, Priglinger S. Role of tissue growth factors in aqueous humor homeostasis. Curr Opin Ophthalmol. 2001;12:94-99.
18. Hu DN, Ritch R. Hepatocyte growth factor is increased in the aqueous humor of glaucomatous eyes. J Glaucoma. 2001;10: 152-157.
19. Wang N, Chintala SK, Fini ME, Schuman JS. Activation of a tissue-specific stress response in the aqueous outflow pathway of the eye defines the glaucoma disease phenotype. Nat Med. 2001;7:304-309.
20. Ooi KG, Galatowicz G, Towler HM, Lightman SL, Calder VL. Multiplex cytokine detection versus ELISA for aqueous humor: IL-5, IL-10, and IFNc profiles in uveitis. Invest Ophthalmol Vis Sci. 2006;47:272-277.
21. Wilson MR, Wotherspoon JS. A new microsphere-based immunofluorescence assay using flow cytometry. J Immunol Methods. 1988;107:225-230.
22. Vignali DA. Multiplexed particle-based flow cytometric assays. J Immunol Methods. 2000;243:243-255.
23. Sharma RK, Rogojina AT, Chalam KV. Multiplex immunoassay analysis of biomarkers in clinically accessible quantities of human aqueous humor. Mol Vis. 2009;15:60-69.
24. Kuchtey J, Rezaei KA, Jaru-Ampornpan P, Sternberg PJ, Kuchtey RW. Multiplex cytokine analysis reveals elevated concentration of interleukin-8 in glaucomatous aqueous humor. Invest Ophthalmol Vis Sci. 2010;51:6441-6447.
25. Takai Y, Tanito M, Ohira A. Multiplex cytokine analysis of aqueous humor in eyes with primary open-angle glaucoma, exfoliation glaucoma, and cataract. Invest Ophthalmol Vis Sci. 2012;53:241-247.
26. Coca-Prados M, Escribano J, Ortego J. Differential gene expression in the human ciliary epithelium. Prog Retin Eye Res. 1999;18:403-429.
27. Perrin R, Craig-Schapiro R, Malone J, et al. Identification and validation of novel cerebrospinal fluid biomarkers for staging early Alzheimer's disease. PLoS One. 2011;6:e16032.
28. Hu W, Chen-Plotkin A, Arnold S, et al. Novel CSF biomarkers for Alzheimer's disease and mild cognitive impairment. Acta Neuropathol. 2010;119:669-678.
29. Craig-Schapiro R, Kuhn M, Xiong C, et al. Multiplexed immunoassay panel identifies novel CSF biomarkers for Alzheimer's disease diagnosis and prognosis. PLoS One. 2011;6:e18850.
30. Vickers JC, Craig JE, Stankovich J, et al. The apolipoprotein e4 gene is associated with elevated risk of normal tension glaucoma. Mol Vis. 2002;8:389-393.
31. Copin B, Brézin AP, Valtot F, Dascotte JC, Béchetoille A, Garchon HJ. Apolipoprotein E-promoter single-nucleotide polymorphisms affect the phenotype of primary open-angle glaucoma and demonstrate interaction with the myocilin gene. Am J Hum Genet. 2002;70:1575-1581.
32. Abdi F, Quinn JF, Jankovic J, et al. Detection of biomarkers with a multiplex quantitative proteomic platform in cerebrospinal fluid of patients with neurodegenerative disorders. J Alzheimers Dis. 2006;9:293-348.
33. Hayashi H, Eguchi Y, Fukuchi-Nakaishi Y, et al. A potential neuroprotective role of apolipoprotein E-containing lipoproteins through low density lipoprotein receptor-related protein 1 in normal tension glaucoma. J Biol Chem. 2012;287:25395- 25406.
34. Shi Z, Rudzinski M, Meerovitch K, et al., a2-Macroglobulin is a mediator of retinal ganglion cell death in glaucoma. J Biol Chem. 2008;283:29156-29165.
35. Bai Y, Dergham P, Nedev H, et al. In chronic and in acute models of retinal neurodegeneration TrkA activity is neuroprotective while p75NTR activity is neurotoxic through a paracrine mechanism. J Biol Chem. 2010;285:39392-39400.
36. Hansson S, Andréasson U, Wall M, et al. Reduced levels of amyloid--binding proteins in cerebrospinal fluid from Alzheimer's disease patients. J Alzheimers Dis. 2009;16:389-397.
37. Kawaji T, Ando Y, Nakamura M, et al. TTR synthesis in rabbit ciliary pigment epithelium. Exp Eye Res. 2005;81:306-312.
38. Kawaji T, Ando Y, Hara R, Tanihara H. Novel therapy for TTRrelated ocular amyloidosis: a pilot study of retinal laser photocoagulation. Ophthalmology. 2010;117:552-555.
39. Bouhenni RA, Al Shahwan S, Morales J, et al. Identification of differentially expressed proteins in the aqueous humor of primary congenital glaucoma. Exp Eye Res. 2011;92:67-75.
40. Saraiva MJ. TTR mutations in hyperthyroxinemia and amyloid diseases. Hum Mutat. 2001;17:493-503.
41. Ando Y, Araki S, Ando M. TTR and familial amyloidotic polyneuropathy. Intern Med. 1993;32:920-922.
42. Ando Y, Nakamura M, Araki S. TTR-related familial amyloidotic polyneuropathy. Arch Neurol. 2005;62:1057-1062.
43. Kimura A, Ando E, Fukushima M, et al. Secondary glaucoma in patients with familial amyloidotic polyneuropathy. Arch Ophthalmol. 2003;121:351-356.